NCT03163303

Smoking Tobacco and Drinking Study

Using Facebook to Address Smoking and Heavy Drinking in Young Adults

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 179 (actual)
• Sponsor: University of California, San Francisco · Academic / Other
• Sex: All
• Age: 18 Years – 25 Years
• Healthy volunteers: Accepted

Summary

This trial will test the efficacy of a 3-month intervention on Facebook targeting tobacco use and heavy episodic drinking against a 3-month Facebook intervention targeting tobacco use. Both groups will be offered a nicotine patch starter kit. The primary outcome is verified 7-day point prevalence abstinence from smoking at 3, 6, and 12 months.

Detailed description

Participants will be randomized to one of two conditions: (1) a Facebook-delivered intervention addressing tobacco use and heavy episodic drinking, tailored to readiness to quit smoking; or (2) a 3-month Facebook intervention targeting tobacco use. Both interventions will include 12 weeks of Facebook-based messages and activities tailored to participants' readiness to quit smoking. Assessments will occur at baseline, 3, 6, and 12 months follow-up. Assessments will include measures on smoking and drinking patterns and thoughts about abstinence. All participants who report no past 7-day smoking will be asked to give biochemical verification of smoking status with saliva cotinine test kits that will be mailed to participants.

Conditions

• Smoking
• Heavy Episodic Drinking

Interventions

Type	Name	Description
BEHAVIORAL	Tobacco Status Project Intervention	90 days of Facebook messaging, weekly live sessions targeting tobacco use
BEHAVIORAL	Tobacco Status Project + Alcohol Intervention	90 days of Facebook messaging, weekly live sessions targeting tobacco use and alcohol use
DRUG	nicotine patch	14-day supply of nicotine patch

Timeline

• Start date: 2017-12-18
• Primary completion: 2019-06-30
• Completion: 2019-06-30
• First posted: 2017-05-23
• Last updated: 2020-08-12
• Results posted: 2020-08-12

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study